Background Studies have shown that individuals may search for suicide-related terms on the internet prior to an attempt. Objective Thus, across 2 studies, we investigated engagement with an advertisement campaign designed to reach individuals contemplating suicide. Methods First, we designed the campaign to focus on crisis, running a campaign for 16 days in which crisis-related keywords would trigger an ad and landing page to help individuals find the national suicide hotline number. Second, we expanded the campaign to also help individuals contemplating suicide, running the campaign for 19 days with a wider range of keywords through a co-designed website with a wider range of offerings (eg, lived experience stories). Results In the first study, the ad was shown 16,505 times and was clicked 664 times (4.02% click rate). There were 101 calls to the hotline. In the second study, the ad was shown 120,881 times and clicked 6227 times (5.15% click rate); of these 6227 clicks, there were 1419 (22.79%) engagements with the site, a substantially higher rate than the industry average of 3%. The number of clicks on the ad was high despite a suicide hotline banner likely being present. Conclusions Search advertisements are a quick, far-reaching, and cost-efficient way of reaching those contemplating suicide and are needed despite suicide hotline banners being present. Trial Registration Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12623000084684; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385209
BackgroundAtrial fibrillation (AF) represents a growing healthcare challenge, mainly driven by acute hospitalisations. Virtual wards could be the way forward to manage acute AF patients through remote monitoring, especially with the rise in global access to digital telecommunication and the growing acceptance of telemedicine post-COVID-19.MethodsAn AF virtual ward was implemented as a proof-of-concept care model. Patients presenting acutely with AF or atrial flutter and rapid ventricular response to the hospital were onboarded to the virtual ward and managed at home through remote ECG-monitoring and ‘virtual’ ward rounds, after being given access to a single-lead ECG device, a blood pressure monitor and pulse oximeter with instructions to record daily ECGs, blood pressure, oxygen saturations and to complete an online AF symptom questionnaire. Data were uploaded to a digital platform for daily review by the clinical team. Primary outcomes included admission avoidance, readmission avoidance and patient satisfaction. Safety outcomes included unplanned discharge from the virtual ward, cardiovascular mortality and all-cause mortality.ResultsThere were 50 admissions to the virtual ward between January and August 2022. Twenty-four of them avoided initial hospital admission as patients were directly enrolled to the virtual ward from outpatient settings. A further 25 readmissions were appropriately prevented during virtual surveillance. Patient satisfaction questionnaires yielded 100% positive responses among participants. There were three unplanned discharges from the virtual ward requiring hospitalisation. Mean heart rate on admission to the virtual ward and discharge was 122±26 and 82±27 bpm respectively. A rhythm control strategy was pursued in 82% (n=41) and 20% (n=10) required 3 or more remote pharmacological interventions.ConclusionThis is a first real-world experience of an AF virtual ward that heralds a potential means for reducing AF hospitalisations and the associated financial burden, without compromising on patients’ care or safety.
Introduction Education is one of the four fundamental pillars of advanced nursing practice (Health Education England, 2017). Despite this, limited educational programmes for nurses working in cardiac specialist practice exist at a local level, outside of structured academic programmes. The RCN (2021) 'Children and Young Peoples Cardiac Nursing Guidance on roles, career pathways and competency development' highlights the importance of continued education at all careers levels within specialist cardiac practice. Methods The 'Cardiac Nurse Specialist: Sharing Knowledge' programme was developed to offer a teaching and education forum which focuses on providing specialist cardiology education for all Cardiac Clinical Nurse Specialists (CCNS) within a tertiary cardiology centre in London, UK. Meeting the outstanding demand to support CCNS education.Bi-monthly sessions are delivered by CCNS's and relevant guest speakers on a range of topics pertinent to specialist cardiology nursing. Subjects covered include cardiac genetics, paediatric arrhythmias, palliative care and the Mental Capacity Act (2005). These sessions are live, interactive meetings hosted on Microsoft Teams and recorded for playback. Results To evaluate the forum, a questionnaire is sent to all CCNS following each educational session. The questionnaire has a mixture of open and closed questions.A total of 38 CCNS are represented in the forum, across fetal cardiology, paediatric congenital heart disease, transition and inherited cardiac conditions specialities. Results from the questionnaire indicate that 100% (n=29) of CCNS found the sessions to be relevant and interesting to their role.79.4% (n=23) CCNS rated the content of the sessions as 'excellent', 17.2% (n=5) 'very good' and 3.4% (n=1) 'good'.The CCNS rated their knowledge levels to increase following the educational sessions on average by 29%. Conclusion This results from the questionnaires show the value of the 'Cardiac Nurse Specialist: Sharing Knowledge' forum in improving CCNS knowledge levels. Further supporting the argument for tailored specialist education for CCNS.The implications for future practice include the potential for extending the forum and educational sessions to hospitals within the network for nurses with an interest in cardiology.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.